Bijin Thajudeen is a Nephrology physician affiliated with University of Arizona. OpenAlex indexes 88 publications with 804 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2800 E Ajo Way
Tucson, AZ 857136204
Telephone
520-874-2778Provider last certified this registry record 30 Mar 2026.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Amgen Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.3%Angiotensin receptor blocker (ARB)9.2%Losartan Potassium85%Candesartan Cilexetil12%Olmesartan Medoxomil3%Part D<11 patientsCalcium channel blocker7.5%Amlodipine Besylate66%Nifedipine Er31%Felodipine Er4%Part D<11 patients+ 16 more classes in this area
Metabolism & gastrointestinal
29%Vitamin D3 Analog8.5%Calcitriol100%Part D≥100 patientsSGLT2 inhibitor8.3%Farxiga57%Jardiance40%Dapagliflozin3%Part D≥55 patients+ 11 more classes in this area
Nervous system
6.8%Gabapentinoids2.2%Gabapentin71%Pregabalin29%Part D<11 patientsOpioid Agonist1.9%Oxycodone Hcl51%Tramadol Hcl50%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The chromatin landscape of healthy and injured cell types in the human kidney
Nature Communications
2024 - Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial
Nephrology Dialysis Transplantation
2024 - Kidney Replacement Therapies in Advanced Heart Failure: Timing, Modalities and Clinical Considerations
Journal of Cardiac Failure
2024 - Thrombotic Microangiopathy Treated with Eculizumab in a Patient with Known Immune Thrombocytopenic Purpura
Journal of the American Society of Nephrology
2024 - Precision Medicine in Nephrology: An Integrative Framework of Multidimensional Data in the Kidney Precision Medicine Project
American Journal of Kidney Diseases
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Eugene Bleecker, MD
University of Arizona
Joseph Alpert, MD
University of Arizona
Lisa Rimsza, MD
University of Arizona
Karl Kern, MD
University of Arizona
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”